Technology Profile
| Title: | A Nanoformulation for Therapeutic Use |
| Value Proposition: | A nanoformulation of L-leucyl-L-leucine methyl ester (LLOMe) and a polymer, for wound healing, tissue and axon regeneration, and tumour therapy. LLOMe nanoformulation offers faster wound healing (≈70–80% closure by day 3), corneal regeneration, tadpole tail regeneration, axon repair, hematopoietic stem cell expansion, antiviral, and antitumor effects—surpassing existing single-application benchmarks. |
| Summary Application: | Wound Healing, Tissue and Axon Regeneration, and Tumour Therapy |
| Advantages: | No current marketed or reported formulation demonstrates multi-modal efficacy across wound healing, regeneration, antiviral, and antitumor applications in a single composition. |
| Tech. Readiness Level: |
CSIR-Centre for Cellular and Molecular Biology[CSIR-CCMB]
: director[at]ccmb[dot]res[dot]in
:91-40-27160222-31, 91-40-27160232-41
:https://www.ccmb.res.in
: director[at]ccmb[dot]res[dot]in
:91-40-27160222-31, 91-40-27160232-41
:https://www.ccmb.res.in
Industrial Applications:
Biological Science Processes/Methods [Biological Science]
Biomolecules [Biological Science]
Biotechnology [Biological Science]
Patent Application(s):
IN202411054279, WO2026018264